Float Short %

4.11

Margin Of Safety %

Put/Call OI Ratio

0.9

EPS Next Q Diff

1.69

EPS Last/This Y

2.63

EPS This/Next Y

0.43

Price

81.53

Target Price

89.93

Analyst Recom

2.25

Performance Q

25.12

Relative Volume

0.82

Beta

1.03

Ticker: COO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	COO	71.35	0.38	0.56	7492
2025-11-18	COO	72.18	0.39	0.11	8032
2025-11-19	COO	72.16	0.39	0.17	8102
2025-11-20	COO	71.1	0.38	1.01	8236
2025-11-21	COO	75.5	0.38	0.97	8334
2025-11-24	COO	76	0.85	0.38	4460
2025-11-25	COO	78.22	0.86	0.10	4635
2025-11-26	COO	77.94	0.74	3.91	5134
2025-12-01	COO	77.33	0.83	0.29	5433
2025-12-02	COO	75.83	0.78	6.20	5664
2025-12-03	COO	75.98	0.82	2.50	5790
2025-12-04	COO	77.01	0.83	1.03	5831
2025-12-05	COO	81.42	0.82	0.85	8973
2025-12-08	COO	78.03	0.86	0.25	8879
2025-12-09	COO	78.43	0.80	1.27	9268
2025-12-10	COO	80.76	0.80	0.47	9308
2025-12-11	COO	82.1	0.84	0.13	10316
2025-12-12	COO	82.02	0.86	0.66	10288
2025-12-15	COO	81.52	0.90	1.91	10409
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-17	COO	71.32	7.3	108.8	4.09
2025-11-18	COO	72.19	7.3	133.5	4.09
2025-11-19	COO	72.15	7.3	124.4	4.09
2025-11-20	COO	71.11	7.3	106.6	4.09
2025-11-21	COO	75.47	7.3	161.1	4.09
2025-11-24	COO	75.97	7.3	121.8	4.09
2025-11-25	COO	78.21	7.3	138.0	4.09
2025-11-26	COO	77.94	7.3	114.5	4.09
2025-12-01	COO	77.41	7.3	112.2	4.09
2025-12-02	COO	75.84	7.3	102.3	4.09
2025-12-03	COO	75.98	7.3	118.4	4.09
2025-12-04	COO	76.95	7.3	126.3	4.09
2025-12-05	COO	81.40	7.1	158.3	4.09
2025-12-08	COO	78.04	11.9	-	4.50
2025-12-09	COO	78.51	11.8	130.1	4.49
2025-12-10	COO	78.51	11.8	155.6	4.51
2025-12-11	COO	82.11	11.8	147.3	4.51
2025-12-12	COO	82.11	11.8	135.0	4.51
2025-12-15	COO	81.53	11.8	109.9	4.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	COO	1.46	3.82	3.27
2025-11-18	COO	1.46	3.82	3.27
2025-11-19	COO	1.46	3.82	3.27
2025-11-20	COO	1.46	3.82	3.27
2025-11-21	COO	1.46	3.82	3.27
2025-11-24	COO	1.41	1.69	3.27
2025-11-25	COO	1.41	1.69	3.27
2025-11-26	COO	1.41	1.69	3.50
2025-12-01	COO	1.41	1.85	3.50
2025-12-02	COO	1.41	1.85	3.50
2025-12-03	COO	1.41	1.85	3.50
2025-12-04	COO	1.41	1.85	3.50
2025-12-05	COO	1.41	1.85	3.50
2025-12-08	COO	1.41	1.78	3.50
2025-12-09	COO	1.41	1.78	3.50
2025-12-10	COO	1.43	1.78	4.06
2025-12-11	COO	1.43	1.78	4.11
2025-12-12	COO	1.43	1.78	4.11
2025-12-15	COO	1.43	1.92	4.11
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="COO" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.62

Avg. EPS Est. Current Quarter

1.03

Avg. EPS Est. Next Quarter

1.07

Insider Transactions

1.43

Institutional Transactions

1.92

Beta

1.03

Average Sales Estimate Current Quarter

1023

Average Sales Estimate Next Quarter

1052

Fair Value

89.05

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

29.7

Max Drawdown 5-Year %

-45.4

Target Price

89.93

P/E

43.51

Forward P/E

16.5

PEG

1.71

P/S

3.9

P/B

1.94

P/Free Cash Flow

36.84

EPS

1.87

Average EPS Est. Cur. Y

4.51

EPS Next Y. (Est.)

4.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.16

Relative Volume

0.82

Return on Equity vs Sector %

-22.4

Return on Equity vs Industry %

-5.4

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.11

EBIT Estimation

109.9

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”COO” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”COO” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”COO” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”COO” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”COO” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”COO” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”COO” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

The Cooper Companies, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 15000

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

stock quote shares COO – The Cooper Companies, Inc. Stock Price stock today

news today COO – The Cooper Companies, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch COO – The Cooper Companies, Inc. yahoo finance google finance

stock history COO – The Cooper Companies, Inc. invest stock market

stock prices COO premarket after hours

ticker COO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: COO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y